Profil
Andrew Keck is associated with Tyme Technologies, Inc. He was the President, CEO, CFO, Secretary & Treasurer of the company from 2011 to 2013.
He is the founder of Tyme Technologies, Inc. which was founded in 2011.
Ehemalige bekannte Positionen von Andrew Keck
| Unternehmen | Position | Ende |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Vorstandsvorsitzender | 26.04.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
